Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues

International Journal of Colorectal Disease

Volumn 23, Issue 7, 2008, Pages 675-682

  Wang, Guiyu ^a   Wang, Xishan ^a   Wang, Shuhuai ^a   Song, Hongtao ^a   Sun, Haiming ^a   Yuan, Weiguang ^a   Cao, Bo ^a   Bai, Jing ^a   Fu, Songbin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Proteomics; S100A11; Tumor marker

Indexed keywords

PROTEIN S 100; PROTEIN S 100A11;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CELL NUCLEUS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

ADULT; AGED; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEOPLASM STAGING; PROTEIN TRANSPORT; S100 PROTEINS; SUBCELLULAR FRACTIONS; UP-REGULATION;

EID: 43449116351     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0464-6     Document Type: Article

References (43)

1. Arkenau HT, Chua YJ, Cunningham D (2007) Current treatment strategies in elderly patients with metastatic colorectal cancer. Clin Colorectal Cancer 7:508-515
2. Smith FM, Gallagher WM, Fox E, Stephens RB, Rexhepaj E, Petricoin EF 3rd, Liotta L, Kennedy MJ, Reynolds JV (2007) Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy. Ann Surg 245:259-266
3. Neal CP, Garcea G, Doucas H, Manson MM, Sutton CD, Dennison AR, Berry DP (2006) Molecular prognostic markers in resectable colorectal liver metastases: A systematic review. Eur J Cancer 42:1728-1743
4. Waterston AM, Cassidy J (2005) Adjuvant treatment strategies for early colon cancer. Drugs 65:1935-1947
5. de Noo ME, Tollenaar RA, Deelder AM, Bouwman LH (2006) Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fears. World J Gastroenterol 12:6594-6601
6. Widel MS, Widel M (2006) Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer. Postepy Hig Med Dosw (Online) 60:453-470
7. Celen O, Kahraman I, Yildirim E, Berberoglu U (2004) Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients. Neoplasma 51:293-299
8. Ahmed FE (2005) Molecular markers that predict response to colon cancer therapy. Expert Rev Mol Diagn 5:353-375
9. Pandey A, Mann M (2000) Proteomics to study genes and genomes. Nature 405:837-846
10. Stulik J, Hernychova L, Porkertova S, Knizek J, Macela A, Bures J, Jandik P, Langridge JI, Jungblut PR (2001) Proteome study of colorectal carcinogenesis. Electrophoresis 22:019-3025
11. Stulik J, Koupilova K, Osterreicher J, Knizek J, Macela A, Bures J, Jandik P, Langr F, Dedic K, Jungblut PR (1999) Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 20:3638-3646
12. Allen BG, Durussel I, Walsh MP, Cox JA (1996) Characterization of the Ca2+-binding properties of calgizzarin (S100C) isolated from chicken gizzard smooth muscle. Biochem Cell Biol 74:687-694
13. Watanabe M, Ando Y, Todoroki H, Minami H, Hidaka H (1991) Molecular cloning and sequencing of a cDNA clone encoding a new calcium binding protein, named calgizzarin, from rabbit lung. Biochem Biophys Res Commun 181:644-649
14. Todoroki H, Kobayashi R, Watanabe M, Minami H, Hidaka H (1991) Purification, characterization, and partial sequence analysis of a newly identified EF-hand type 13-kDa Ca(2+)-binding protein from smooth muscle and non-muscle tissues. J Biol Chem 266:18668-18673
15. Naka M, Qing ZX, Sasaki T, Kise H, Tawara I, Hamaguchi S, Tanaka T (1994) Purification and characterization of a novel calcium-binding protein, S100C, from porcine heart. Biochim Biophys Acta 1223:348-353
16. Ohta H, Sasaki T, Naka M, Hiraoka O, Miyamoto C, Furuichi Y, Tanaka T (1991) Molecular cloning and expression of the cDNA coding for a new member of the S100 protein family from porcine cardiac muscle. FEBS Lett 295:93-96
17. Sakaguchi M, Miyazaki M, Inoue Y, Tsuji T, Kouchi H, Tanaka T, Yamada H, Namba M (2000) Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts. J Cell Biol 149:1193-1206
18. Sakaguchi M, Tsuji T, Inoue Y, Miyazaki M, Namba M, Yamada H, Tanaka T (2001) Loss of nuclear localization of the S100C protein in immortalized human fibroblasts. Radiat Res 155:208-214
19. Yao R, Davidson DD, Lopez-Beltran A, MacLennan GT, Montironi R, Cheng L (2007) The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol 22:1025-1032
20. Sakaguchi M, Miyazaki M, Kondo T, Namba M (2001) Up-regulation of S100C in normal human fibroblasts in the process of aging in vitro. Exp Gerontol 36:1317-1325
21. Salama I, Malone PS, Mihaimeed F, Jones JL (2007) A review of the S100 proteins in cancer. Eur J Surg Oncol DOI 10.1016/j.ejso.2007.04.009
22. Kondo A, Sakaguchi M, Makino E, Namba M, Okada S, Huh NH (2002) Localization of S100C immunoreactivity in various human tissues. Acta Med Okayama 56:31-34
23. Garrett SC, Varney KM, Weber DJ, Bresnick AR (2006) S100A4, a mediator of metastasis. J Biol Chem 281:677-680
24. Ilg EC, Schafer BW, Heizmann CW (1996) Expression pattern of S100 calcium-binding proteins in human tumors. Int J Cancer 68:325-332
25. Lof AL, Gustafsson G, Novak V, Engman L, Mikaelsson M (1992) Determination of total protein in highly purified factor IX concentrates. Vox Sang 63:172-177
26. Van den Bergh G, Clerens S, Cnops L, Vandesande F, Arckens L (2003) Fluorescent two-dimensional difference gel electrophoresis and mass spectrometry identify age-related protein expression differences for the primary visual cortex of kitten and adult cat. J Neurochem 85:193-205
27. Yip MP, Tu SP, Chun A, Yasui Y, Taylor VM (2006) Participation in colorectal cancer screening among Chinese Americans. Asian Pac J Cancer Prev 7:645-650
28. Robinson NA, Lapic S, Welter JF, Eckert RL (1997) S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J Biol Chem 272:12035-12046
29. Bertagnolli MM (2007) Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: Two steps forward, one step back. Lancet Oncol 8:439-443
30. Wang XS, Wang K, Li X, Fu SB (2004) Effects of phosphorothioate anti-sense oligodeoxynucleotides on colorectal cancer cell growth and telomerase activity. World J Gastroenterol 10:3455-3458
31. Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ (2006) Proteomic identification of new biomarkers and application in thyroid cytology. Acta Cytol 50:518-528
32. Tian T, Hao J, Xu A, Hao J, Luo C, Liu C, Huang L, Xiao X, He D (2007) Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 98(8):1265-1274
33. Song HY, Liu YK, Feng JT, Cui JF, Dai Z, Zhang LJ, Feng JX, Shen HL, Tang ZY (2006) Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 132:92-98
34. Memon AA, Sorensen BS, Meldgaard P, Fokdal L, Thykjaer T, Nexo E (2005) Down-regulation of S100C is associated with bladder cancer progression and poor survival. Clin Cancer Res 11:606-611
35. Quirke P, Williams GT, Ectors N, Ensari A, Piard F, Nagtegaal I (2007) The future of the TNM staging system in colorectal cancer: Time for a debate? Lancet Oncol 8:651-657
36. Lee SH (2006) TNM staging, molecular staging and prognostic factors of rectal cancer. Korean J Gastroenterol 47:291-294
37. Horton JK, Tepper JE (2005) Staging of colorectal cancer: Past, present, and future. Clin Colorectal Cancer 4:302-312
38. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979-994
39. Booth RA (2007) Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett 249:87-96
40. Karantanas AH, Yarmenitis S, Papanikolaou N, Gourtsoyiannis N (2007) Preoperative imaging staging of rectal cancer. Dig Dis 25:20-32
41. Komatsu Y (2007) Adjuvant chemotherapy for colorectal cancer in Japan-current state and problem areas. Gan To Kagaku Ryoho 34:799-807
42. Daniels IR, Fisher SE, Heald RJ, Moran BJ (2007) Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: A review of the recent evidence. Colorectal Dis 9:290-301
43. Inada H, Naka M, Tanaka T, Davey GE, Heizmann CW (1999) Human S100A11 exhibits differential steady-state RNA levels in various tissues and a distinct subcellular localization. Biochem Biophys Res Commun 263:135-138